Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers A Krzeslak, K Wojcik-Krowiranda, E Forma, P Jozwiak, H Romanowicz, ... Pathology & Oncology Research 18, 721-728, 2012 | 301 | 2012 |
O-GlcNAcylation and Metabolic Reprograming in Cancer P Jóźwiak, E Forma, M Bryś, A Krześlak Frontiers in endocrinology 5, 145, 2014 | 146 | 2014 |
Gene expression of O-GlcNAc cycling enzymes in human breast cancers A Krześlak, E Forma, M Bernaciak, H Romanowicz, M Bryś Clinical and experimental medicine 12, 61-65, 2012 | 121 | 2012 |
Anticancer activity of propolis and its compounds E Forma, M Bryś Nutrients 13 (8), 2594, 2021 | 108 | 2021 |
Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α … K Starska, E Forma, P Jóźwiak, M Bryś, I Lewy-Trenda, ... Tumor Biology 36, 2309-2321, 2015 | 84 | 2015 |
Concentration of cadmium, nickel and aluminium in female breast cancer H Romanowicz-Makowska, E Forma, M Bryś, WM Krajewska, B Smolarz Polish Journal of Pathology 62 (4), 257-261, 2011 | 79 | 2011 |
Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level W Rozanski, A Krzeslak, E Forma, M Brys, M Blewniewski, P Wozniak, ... Clinical laboratory 58 (5), 579, 2012 | 74 | 2012 |
Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer A Krześlak, E Forma, P Jóźwiak, A Szymczyk, B Smolarz, ... Clinical and experimental medicine 14, 107-113, 2014 | 48 | 2014 |
Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations A Krześlak, E Forma, M Bryś, K Wójcik-Krowiranda, A Bieńkiewicz Ginekologia polska 83 (1), 2012 | 43 | 2012 |
The potential role of O-GlcNAc modification in cancer epigenetics E Forma, P Jóźwiak, M Bryś, A Krześlak Cellular and Molecular Biology Letters 19 (3), 438-460, 2014 | 41 | 2014 |
Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer A Krześlak, E Forma, G Chwatko, P Jóźwiak, A Szymczyk, J Wilkosz, ... Toxicology and applied pharmacology 268 (3), 278-285, 2013 | 41 | 2013 |
Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer K Starska, E Forma, I Lewy-Trenda, O Stasikowska-Kanicka, M Skóra, ... Cellular Oncology 41, 253-268, 2018 | 39 | 2018 |
Differential expression of ten-eleven translocation genes in endometrial cancers P Ciesielski, P Jóźwiak, K Wójcik-Krowiranda, E Forma, Ł Cwonda, ... Tumor Biology 39 (3), 1010428317695017, 2017 | 38 | 2017 |
The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma. K Starska, E Forma, I Lewy-Trenda, O Stasikowska, M Bryś, ... Folia Histochemica et Cytobiologica 47 (3), 401-410, 2009 | 35 | 2009 |
Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions P Jóźwiak, P Ciesielski, A Zaczek, A Lipińska, L Pomorski, M Wieczorek, ... Journal of Biomedical Science 24, 1-10, 2017 | 33 | 2017 |
Polymorphisms of Homologous Recombination RAD51, RAD51B, XRCC2, and XRCC3 Genes and the Risk of Prostate Cancer M Nowacka-Zawisza, E Wiśnik, A Wasilewski, M Skowrońska, E Forma, ... Analytical Cellular Pathology 2015 (1), 828646, 2015 | 33 | 2015 |
Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer K Starska, E Forma, E Brzezińska-Błaszczyk, I Lewy-Trenda, M Bryś, ... Clinical and experimental medicine 15, 455-468, 2015 | 32 | 2015 |
Relationship of urinary isoprostanes to prostate cancer occurence M Brys, A Morel, E Forma, A Krzeslak, J Wilkosz, W Rozanski, B Olas Molecular and cellular biochemistry 372, 149-153, 2013 | 32 | 2013 |
Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population E Forma, A Krzeslak, J Wilkosz, P Jozwiak, A Szymczyk, W Rozanski, ... Cancer Genetics 205 (9), 432-435, 2012 | 32 | 2012 |
Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells E Forma, P Jóźwiak, P Ciesielski, A Zaczek, K Starska, M Bryś, A Krześlak PLoS One 13 (6), e0198351, 2018 | 31 | 2018 |